Intensified polarization for R&D among listed pharmas

Published: 2017-08-18 16:30:00
Updated: 2017-08-18 11:27:20

R&D polarization is being intensified among listed pharmaceutical companies.

While there is a company investing more than 20% of their sales, a number of companies are still spending less than 1% of their sales into R&D.

Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceuti...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.